Lazard reports Q2 profit on investment banking rebound-February 2024-www.financetom.com

Lazard reports Q2 profit on investment banking rebound

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Lazard reports Q2 profit on investment banking rebound

Jul 25, 2024 4:06 AM

July 25 (Reuters) - Lazard ( LAZ ) reported a profit for

the second quarter on Thursday, driven by a recovery in its core

investment banking business.

The bank posted net income of $50 million, or 49 cents per

share, in the three months ended June 30. That compares with a

loss of $124 million, or $1.41 per share, in the year-ago

period.

Previous page： Birkenstock lifts sales outlook on demand boost for clogs and shoes Next page： Birkenstock Expects to Exceed Fiscal 2025 Revenue Guidance; Buys Factory in Germany

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Birkenstock lifts sales outlook on demand boost for clogs and shoes

Sep 25, 2025

Sept 25 (Reuters) - German sandal maker Birkenstock ( BIRK ) on Thursday raised its expectations for fiscal year 2025 revenue, driven by demand for its clogs and shoes from affluent shoppers despite price hikes. The company now expects sales of at least 2.09 billion euros ($2.45 billion), implying growth of about 17.5% at constant currency rates over last year....

Birkenstock Expects to Exceed Fiscal 2025 Revenue Guidance; Buys Factory in Germany

Sep 25, 2025

04:06 AM EDT, 09/25/2025 (MT Newswires) -- Birkenstock ( BIRK ) said Thursday it now expects fiscal 2025 revenue of at least 2.09 billion euros ($2.45 billion), surpassing its previous guidance. Analysts surveyed by FactSet expect 2.09 billion euros. The company also said it acquired a production facility near Dresden, Germany, for a net price of 18 million euros, with...

MBX Biosciences Prices Upsized $200 Million Common Stock Offering

Sep 25, 2025

04:09 AM EDT, 09/25/2025 (MT Newswires) -- MBX Biosciences ( MBX ) said late Wednesday it priced its upsized public offering of 11.1 million common shares at $18 each, for about $199.9 million in expected gross proceeds. Underwriters have a 30-day overallotment option to purchase up to 1.7 million additional shares. The offering is expected to close Friday. ...

UK secures commitments from Ticketmaster after Oasis tour issue

Sep 25, 2025

LONDON, Sept 25 (Reuters) - Britain's competition regulator has secured formal commitments from Ticketmaster to ensure customers have the information they need when they buy tickets from the entertainment and event group's platform, the watchdog said on Thursday. Thousands of fans waited for hours online to get their hands on tickets for the British band Oasis's reunion shows this summer,...